Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

James N. Kochenderfer, MD, Discusses the KarMMa Clinical Trial

 

In this video, Dr Kochenderfer of the National Cancer Institute discusses the findings and clinical significance of the KarMMA study, which looked at the use of anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma (MM).

Advertisement

Advertisement

Advertisement

Advertisement